Until recently, keratin has long been considered to have the singular function of providing structure to cells and tissue. Now, Cell Constructs has identified another important function for human keratin – as an active wound care matrix. It’s estimated that 14 million people suffer from chronic wounds annually. Complications from chronic wounds can lead to debilitating and life-threatening complications as well as increased healthcare costs.1
Recent published evidence suggests that human keratin’s role as a biomaterial may serve even more purposes. As research moves forward, the scientific evidence supporting the benefits of human keratin continues to expand.
1 Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-7.
The unique characteristics of ProgenaMatrix make it a biocompatible primary wound matrix and protective barrier. ProgenaMatrix is engineered to be transparent, allowing for wound visualization during treatment. ProgenaMatrix is packaged fully hydrated and capable of delivering moisture to the wound bed. As healing is induced and wound margins shrink, ProgenaMatrix is designed to lift up and away as tissue heals. By limiting contact with the peri-wound tissue, the risk of maceration diminishes substantially.1
1. Mikel G, Weir D. Prevention and Treatment of Moisture-Associated Skin Damage (Maceration) in the Periwound Skin. Journal of Wound, Ostomy, and Continence Nursing. 2007; 34, 2: 153-157.
ProgenaMatrix is currently undergoing a 510k premarket review by FDA for dry, light and moderately exuding partial and full thickness wounds. Not available for sale or other clinical use.